U.S. FDA approves Sanofi's MS drug Lemtrada
November 15, 2014 at 10:13 AM EST
PARIS, Nov 15 (Reuters) - The U.S. Food and Drug Administration has approved Sanofi's multiple sclerosis treatment Lemtrada, Sanofi said in a statement on Saturday.
